drugset / Trial / NCT01207206

Oral Ketamine as an Adjuvant to Opioids for Pain Treatment in Cancer Patients

NCT01207206 ↗

Unknown 50 enrolled Tel-Aviv Sourasky Medical Center
RandomizedParallel-groupQuadruple-blindTreatment

Summary

In the current research the investigators would like to examine the effect of a well acquainted drug, Ketamine, which is used by anesthesiologists to induce sleep in operations. Usually the ketamine is given into the vein and not orally. The investigators want to give it orally to cancer patients that sufffer from severe pain to find out whether it can prove their quality of life, lower their pain and reduce the amount of opioids they receive.

Timeline

Start
2010-10
Primary completion
2012-10
Completion
2012-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule — Oral

Indications